Verrica Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
15.12.23
/
50%
€5.10
Target price
15.12.24
€9.18
Performance (%)
-68.69%
Price
16.09.24
€1.69
Summary
This prediction is currently active. Massive losses of -68.69% have been the result for the BUY prediction by Jefferies_Financial_. This prediction currently runs until 15.12.24. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | -3.916% | -3.916% |
iShares Core DAX® | 1.887% | 1.967% |
iShares Nasdaq 100 | 2.316% | -1.227% |
iShares Nikkei 225® | 1.134% | 0.390% |
iShares S&P 500 | 1.821% | 0.790% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat